The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
The purpose of this study is to evaluate efficacy and safety of additional hyaluronic acid/chondroitin sulfate to transurethral resection of bladder ulcer in patient with interstitial cystitis.
This is a randomized, parallel, 6 month period study.
Inclusion Criteria:
Exclusion Criteria:
Scheduled for or use of intravesical therapy (eg, bladder distention,transurethral resection of bladder ulcer, instillation) during or within 6months prior to the study and use of pentosan polysulfate sodium within 1 months prior to the study
Patients who are pregnancy or, childbearing age without no contraception
Patients with voided volume <40 or, > 400ml
Patients with microscopic hematuria, (≥1+ in dipstick), If not excluded that no evidence of neoplastic tumor examination
Patients with urine culture showing evidence of urinary tract infection 1month prior to the study
Accompanied medical problem below
Patients had prior surgery (eq, bladder augmentation, cystectomy
Patients with neurologic disorder
Patients with indwelling catheter or intermittent self-catheterization
Patients with psychologic problem